Kyle Beilman - 27 Jan 2026 Form 4 Insider Report for Dave Inc./DE (DAVE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Jan 2026, 09:15:42 UTC
Prior SEC filing
03 Dec 2025
Next SEC filing
11 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joan Aristei as Attorney-in-Fact for Kyle Beilman

Key filing fact

Kyle Beilman filed Form 4 for Dave Inc./DE (DAVE) on 28 Jan 2026.

Key facts

  • This page summarizes Kyle Beilman's Form 4 filing for Dave Inc./DE (DAVE).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 28 Jan 2026, 09:15.

Change

  • Previous filing in this sequence was filed on 03 Dec 2025.
  • Current net transaction value: +$7,100.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001889438 Primary reporting owner

Beilman Kyle

Relationship
CFO and COO and Secretary
Address
1265 SOUTH COCHRAN AVE, LOS ANGELES
Signature
/s/ Joan Aristei as Attorney-in-Fact for Kyle Beilman
Signature date
28 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DAVE transaction

Class A Common Stock

Options Exercise

Transaction value
$7,100
Shares
+5,000
Change %
+3.3%
Price
$1.42
Shares after
155,556
Date
27 Jan 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DAVE transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-5,000
Change %
-18%
Price
$0.000000
Shares after
22,958
Date
27 Jan 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
5,000
Exercise price
$1.42
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The exercise price and the number of securities reported herein have been adjusted to reflect the 1-for-32 reverse stock split effected by the Issuer on January 5, 2023.

Footnote F2

The option vested 25% on July 15, 2019 and 1/48th monthly thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .